ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
22.50% (1D)
| Bid | n/a |
| Market Cap | 9.35M |
| Revenue (ttm) | 7.17M |
| Net Income (ttm) | -3.46M |
| EPS (ttm) | -830.44 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 13,589,255 |
| Avg. Volume (20D) | 884,118 |
| Open | 3.06 |
| Previous Close | 3.20 |
| Day's Range | 2.80 - 4.65 |
| 52-Week Range | 2.80 - 1212.99 |
| Beta | 1.90 |
About RSLS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RSLS
Website n/a
1 month ago
-6.11%
RSLS stock has given up its prior gain. ReShape Li...
Unlock content with
Pro Subscription
1 month ago
-6.11%
ReShape Lifesciences shares are trading higher after the company announced it was granted an institutional patent from the Australian Patent Office for its Diabetes Neuromodulation technology.
20 hours ago · businesswire.com
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND TomorrowCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with l...
